Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ — Investor Relations & Filings

Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,017 across all filing types
Latest filing 2012-06-29 Annual Report
Country US United States of America
Listing US MLAB

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
10-K
Annual Report FY 2012
2012-06-29 English
PRIMARY DOCUMENT
Director's Dealing
2012-06-26 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 23, 2012, for Mesa Laboratories, Inc. It specifically references "ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION" and states that a press release describing results of operations for the fourth quarter and fiscal year ended March 31, 2012, is attached as Exhibit 99.1. The document itself is short (2558 characters) and primarily serves to announce the release of financial results via a press release. There is no detailed financial data or comprehensive report within this document itself, only a reference to the press release. According to the "MENU VS MEAL" rule, this is an announcement of a report (press release) rather than the report itself. Therefore, the appropriate classification is Earnings Release (ER), as the press release contains the initial announcement of quarterly and annual financial results.
2012-05-23 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 21, 2012, reporting the entry into a material definitive agreement and the completion of an asset acquisition by Mesa Laboratories, Inc. It details the terms of the acquisition agreement, including payment and contingent consideration. The document also states that financial statements related to the acquired business are not yet available but will be filed later by amendment. The content focuses on the announcement of a significant acquisition transaction and related agreements, which fits the category of Capital/Financing Update (CAP). It is not an annual or quarterly report, audit report, or earnings release. It is not a proxy, voting result, or management change announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the transaction, not just a brief announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2012-05-21 English
PRIMARY DOCUMENT
Director's Dealing
2012-04-18 English
PRIMARY DOCUMENT
Director's Dealing
2012-04-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.